Holen Sie sich die Stockscreener-App
1.30
2.36%
0.03
Handel nachbörslich:
1.23
-0.07
-5.38%
Schlusskurs vom Vortag:
$1.27
Offen:
$1.32
24-Stunden-Volumen:
409.40K
Relative Volume:
0.38
Marktkapitalisierung:
$17.17M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.51M
KGV:
-0.9848
EPS:
-1.32
Netto-Cashflow:
$-8.02M
1W Leistung:
-1.52%
1M Leistung:
-9.72%
6M Leistung:
+21.50%
1J Leistung:
+114.38%
1-Tages-Spanne:
$1.22
$1.3326
1-Wochen-Bereich:
$1.14
$1.3326
52-Wochen-Spanne:
$0.585
$3.80
Hoth Therapeutics Inc Stock (HOTH) Company Profile
Firmenname
Hoth Therapeutics Inc
Sektor
Branche
Telefon
(646)756-2997
Adresse
1177 AVENUE OF THE AMERICAS, NEW YORK, NY
Vergleichen Sie HOTH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HOTH
Hoth Therapeutics Inc
|
1.30 | 15.32M | 0 | -7.51M | -8.02M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Hoth Therapeutics Inc Stock (HOTH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-10-15 | Eingeleitet | The Benchmark Company | Speculative Buy |
Hoth Therapeutics Inc Aktie (HOTH) Neueste Nachrichten
Hoth Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Is Hoth Therapeutics Inc. part of any major indexRocket Fuel Portfolio Alerts - classian.co.kr
Is Hoth Therapeutics Inc. forming a double bottomBest Small Caps with Big Returns - newsyoung.net
Using Bollinger Bands to evaluate Hoth Therapeutics Inc.Free Safe Entry Stock Watch Suggestions - Newser
Hoth Therapeutics Inc. stock trend outlook and recovery pathROI Focused Setup Screener With Exit Markers - Newser
What momentum shifts mean for Hoth Therapeutics Inc.Free Community Entry Consensus Trade Ideas - Newser
How to integrate Hoth Therapeutics Inc. into portfolio analysis toolsFree Entry and Exit Strategy Optimizer Tool - Newser
Why Hoth Therapeutics Inc. stock attracts strong analyst attentionDaily Technical Forecast for Quick Gains - Newser
Relative strength of Hoth Therapeutics Inc. in sector analysisFree Daily Chart Pattern Stock Forecast - Newser
Reversal indicators forming on Hoth Therapeutics Inc. stockDaily Pick Forecast with Entry Zones - Newser
Hoth Therapeutics Holds Annual Shareholder Meeting - The Globe and Mail
When is Hoth Therapeutics Inc. stock expected to show significant growthBreakthrough stock performance - Jammu Links News
How strong is Hoth Therapeutics Inc. company’s balance sheetOverwhelming profit margins - Jammu Links News
Is Hoth Therapeutics Inc. a good long term investmentStay informed with expert market forecasts - Jammu Links News
What institutional investors are buying Hoth Therapeutics Inc. stockInvest smarter with comprehensive market analysis - Jammu Links News
Hoth Therapeutics Inc. Stock Analysis and ForecastBuild wealth steadily with proven methods - Jammu Links News
Does Hoth Therapeutics Inc. stock perform well during market downturnsPhenomenal wealth increase - Jammu Links News
What catalysts could drive Hoth Therapeutics Inc. stock higher in 2025Breakthrough stock performance - Jammu Links News
What is the risk reward ratio of investing in Hoth Therapeutics Inc. stockBuild wealth faster with professional insights - Jammu Links News
Why is Hoth Therapeutics Inc. stock attracting strong analyst attentionInvest smarter with actionable market insights - Jammu Links News
How many analysts rate Hoth Therapeutics Inc. as a “Buy”Earnings Report Growth Plan For Smart Trading - Jammu Links News
Hoth Therapeutics (HOTH) Expected to Announce Quarterly Earnings on Friday - Defense World
Hoth Therapeutics Regains Nasdaq ComplianceClears Key Listing Hurdle, Reaffirms Path Toward Growth - 富途牛牛
What are the latest earnings results for Hoth Therapeutics Inc.Wealth Building Picks That Work - Jammu Links News
What makes Hoth Therapeutics Inc. stock price move sharplyBest Dividend Data Feed To Watch Now - Jammu Links News
Is a relief rally coming for Hoth Therapeutics Inc. holdersWeekly Return Plan for Conservative Traders - Newser
Hoth Therapeutics Engages ICON to Expand Clinical Trial for HT-001 - Contract Pharma
Hoth Therapeutics Inc. Flashes Rebound Signal in Oversold ConditionInvestment Strategy Designed for Capital Protection - metal.it
Hoth Therapeutics to expand phase II trial of HT-001 to EU countries - Investing.com
Cancer Treatment Breakthrough: Hoth Therapeutics Takes Phase II Trial Global with Major EU Expansion - Stock Titan
What is the dividend policy of Hoth Therapeutics Inc. stockDaily Trading Forecasts From AI Tools - Jammu Links News
Published on: 2025-07-28 20:31:38 - metal.it
Hoth Therapeutics’ (HOTH) Buy Rating Reiterated at D. Boral Capital - Defense World
What analysts say about Hoth Therapeutics Inc. stockFree Wealth Management Insights - Autocar Professional
What drives Hoth Therapeutics Inc. stock priceFree Trading Strategy Suggestions - Autocar Professional
Finanzdaten der Hoth Therapeutics Inc-Aktie (HOTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):